ClinicalTrials.gg
CompletedNCT07808710Updated Sep 9, 2026

Effects of the Q-Collar During High-Intensity Cycling Exercise

An interventional study of Q-Collar™ in Physiological Responses to High-Intensity Exercise, sponsored by University of Northern Iowa. Completed at 1 site in United States. Open to male participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by University of Northern Iowa · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Primary completion was May 2024, 2 years 6 months ago, and no results have been posted to the registry.
  • Registered 2 years 5 months after the study started (first participant enrolled Mar 2024, registered Aug 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Male
01

Study summary

This study examined the effects of wearing the Q-Collar during high-intensity cycling exercise. Eleven recreationally trained male participants completed two 5-kilometer cycling time trials: one while wearing the Q-Collar and one without the Q-Collar. During and after each trial, researchers measured cardiovascular responses, brain oxygenation, blood lactate, perceived exertion, cognitive performance, and cycling performance. The purpose of the study was to determine whether wearing the Q-Collar affects physiological responses, cognitive function, or performance during high-intensity exercise.

Read the detailed description

This randomized crossover study examined the effects of Q-Collar use during high-intensity cycling exercise. Recreationally trained male participants completed two laboratory testing sessions in randomized order: a 5-kilometer cycling time trial while wearing the Q-Collar and a 5-kilometer cycling time trial without the Q-Collar. The Q-Collar applies mild bilateral compression to the internal jugular veins and is designed to increase cerebral blood volume.

During each trial, cardiovascular responses were assessed continuously, while prefrontal cortex oxygenation was measured using functional near-infrared spectroscopy. Blood lactate and ratings of perceived exertion were assessed during exercise, and cognitive performance was evaluated before and after each cycling trial. Cycling performance was also recorded.

The study was designed to determine whether wearing the Q-Collar alters physiological responses to high-intensity exercise, particularly cardiovascular function and prefrontal cortex oxygenation, and whether these responses are accompanied by changes in cognitive or cycling performance. The crossover design allowed each participant to complete both conditions and therefore serve as his own control.

02

Conditions studied

  • Physiological Responses to High-Intensity Exercise

Keywords

  • Q-collar
  • Jugular vein compression
  • Functional near-infrared spectroscopy
  • Prefrontal cortex oxygenation
  • Cognitive performance
  • Cycling performance
03

In context

Lead sponsor

University of Northern Iowa is the lead sponsor of 5 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male participants
  • 18-35 years old
  • Recreationally trained
  • Provided written
  • Achieved a maximal oxygen consumption (VO₂max) classified as "good" or "excellent" during cardiopulmonary exercise testing

Exclusion criteria

Exclusion Criteria:

  • Failure to meet the required "good" or "excellent" VO₂max classification during cardiopulmonary exercise testing
  • Outside age range
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    Q-Collar Then Control

    Participants completed a 5-kilometer cycling time trial while wearing the Q-Collar, followed by a control 5-kilometer cycling time trial without the Q-Collar after a washout period of at least 72 hours.

    Device: Q-Collar™

  • Experimental
    Control Then Q-Collar

    Participants completed a control 5-kilometer cycling time trial without the Q-Collar, followed by a 5-kilometer cycling time trial while wearing the Q-Collar after a washout period of at least 72 hours.

    Device: Q-Collar™

Interventions

  • DeviceQ-Collar™

    The Q-Collar™ is a wearable neck device that applies mild bilateral compression to the internal jugular veins. Participants wore the Q-Collar during a 5-kilometer cycling time trial. The device was individually fitted according to manufacturer guidelines and remained in place throughout the exercise trial.

06

What researchers measure

Primary outcomes

  1. Prefrontal Cortex Oxygenation

    Changes in prefrontal cortex oxygenated hemoglobin were continuously measured using functional near-infrared spectroscopy during 5-kilometer cycling time trials performed with and without the Q-Collar. Data were evaluated across kilometer time points.

    Time frame: All throughout each 5-kilometer cycling time trial, approximately 10 minutes

Secondary outcomes

  1. Cycling Time-Trial Performance

    Time in seconds required to complete the 5-kilometer cycling time trial was recorded for the Q-Collar and control conditions.

    Time frame: At completion of each 5-kilometer cycling time trial, approximately 30 seconds

  2. Choice Reaction Time

    Choice reaction time was assessed using a computerized Stroop task. Reaction time and response accuracy were evaluated across the Q-Collar and control conditions.

    Time frame: At baseline, 5 minutes into exercise, immediately post-exercise, and 10 minutes post-exercise during each experimental visit, approximately 2 minutes at each time point

  3. Heart Rate

    Heart rate was continuously assessed using cardiac impedance and compared across the Q-Collar and control conditions.

    Time frame: During each 5-kilometer cycling time trial, approximately 10 minutes

  4. Stroke Volume

    Stroke volume was continuously assessed using cardiac impedance and compared across the Q-Collar and control conditions.

    Time frame: During each 5-kilometer cycling time trial, approximately 10 minutes

  5. Cardiac Output

    Cardiac output was continuously assessed using cardiac impedance and compared across the Q-Collar and control conditions.

    Time frame: During each 5-kilometer cycling time trial, approximately 10 minutes

  6. Blood Lactate

    Blood lactate concentration (mmol/L) was measured from an earlobe capillary blood sample immediately following each cycling time trial.

    Time frame: Immediately following each 5-kilometer cycling time trial, approximately 1 minute

  7. Rating of Perceived Exertion

    Rating of perceived exertion was assessed using the Borg 6-20 scale immediately following each 5-kilometer cycling time trial.

    Time frame: Immediately following each 5-kilometer cycling time trial, approximately 30 seconds

07

Study locations

1 site
  • University of Northern Iowa
    Cedar Falls, Iowa 50614, United States
08

References and documents

Individual participant data

Plan to share: No — There is no current plan for public sharing of individual participant data; however, de-identified data may be considered upon reasonable request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2024 to primary completion in May 2024, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 27, 2026
First posted
Sep 9, 2026
StartActual
Mar 20, 2024
Primary completionActual
May 8, 2024
CompletionActual
May 8, 2024
Last update
Sep 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07808710
Lead sponsor
University of Northern Iowa
Responsible party
Sponsor
First posted
Sep 9, 2026
Start date
Mar 20, 2024
Primary completion
May 8, 2024
Completion
May 8, 2024
Last update
Sep 9, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion